Benjamin R. Hinatsu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Benjamin R. Hinatsu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Brett E. Pickett
Microbiology and Molecular Biology, Brigham Young University
1 shared publication - Curtis S. Hoffmann
Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA
1 shared publication - Ethan J. Beausoleil
Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA
1 shared publication - John Krapohl
Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA
1 shared publication - Kennedy T. L. Gifford
Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA
1 shared publication - Makayla Komer
Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84062, USA
1 shared publication
Latest Publications
- Open Access
Preprocessing of Public RNA-Sequencing Datasets to Facilitate Downstream Analyses of Human Diseases
Publicly available RNA-sequencing (RNA-seq) data are a rich resource for elucidating the mechanisms of human disease; however, preprocessing these data requires considerable bioinformatic expertise and computational infrastructure. Analyzing multiple datasets with a consistent computational workflow increases the accuracy of downstream meta-analyses. This collection of datasets represents the human intracellular transcriptional response to disorders and diseases such as acute lymphoblastic leukemia (ALL), B-cell lymphomas, chronic obstructive pulmonary disease (COPD), colorectal cancer, lupus erythematosus; as well as infection with pathogens including Borrelia burgdorferi, hantavirus, influenza A virus, Middle East respiratory syndrome coronavirus (MERS-CoV), Streptococcus pneumoniae, respiratory syncytial virus (RSV), severe acute respiratory syndrome coronavirus (SARS-CoV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We calculated the statistically significant differentially expressed genes and Gene Ontology terms for all datasets. In addition, a subset of the datasets also includes results from splice variant analyses, intracellular signaling pathway enrichments as well as read mapping and quantification. All analyses were performed using well-established algorithms and are provided to facilitate future data mining activities, wet lab studies, and to accelerate collaboration and discovery.
Open AccessPreprocessing of Public RNA-Sequencing Datasets to Facilitate Downstream Analyses of Human Diseases
Publicly available RNA-sequencing (RNA-seq) data are a rich resource for elucidating the mechanisms of human disease; however, preprocessing these data requires considerable bioinformatic expertise and computational infrastructure. Analyzing multiple datasets with a consistent computational workflow increases the accuracy of downstream meta-analyses. This collection of datasets represents the human intracellular transcriptional response to disorders and diseases such as acute lymphoblastic leukemia (ALL), B-cell lymphomas, chronic obstructive pulmonary disease (COPD), colorectal cancer, lupus erythematosus; as well as infection with pathogens including Borrelia burgdorferi, hantavirus, influenza A virus, Middle East respiratory syndrome coronavirus (MERS-CoV), Streptococcus pneumoniae, respiratory syncytial virus (RSV), severe acute respiratory syndrome coronavirus (SARS-CoV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We calculated the statistically significant differentially expressed genes and Gene Ontology terms for all datasets. In addition, a subset of the datasets also includes results from splice variant analyses, intracellular signaling pathway enrichments as well as read mapping and quantification. All analyses were performed using well-established algorithms and are provided to facilitate future data mining activities, wet lab studies, and to accelerate collaboration and discovery.